First Horizon Advisors’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
Other funds holding HAE
RA
First Horizon Advisors's HAE Position: Q4 2024 in Review
First Horizon Advisors sold out of Haemonetics (HAE) in Q4 2024, closing a stake of 45 shares — an estimated $3.62K sold.
First Horizon Advisors first reported a position in HAE in Q1 2014 and held it in 26 quarters. The position peaked at $19K in Q4 2020. 309 funds tracked by Wall St. Rank hold HAE as of Q4 2024.
- First Horizon Advisors reported no remaining Haemonetics position as of Q4 2024 after selling out during the quarter.
- First Horizon Advisors sold 45 Haemonetics shares in Q4 2024, an estimated $3.62K.
- First Horizon Advisors first reported a position in Haemonetics in Q1 2014 and held it in 26 quarters.
- First Horizon Advisors's Haemonetics position peaked at $19K in Q4 2020.
- 309 funds tracked by Wall St. Rank held Haemonetics as of Q4 2024.
Based on First Horizon Advisors's 13F filing for Q4 2024, filed 3 Feb 2025.